Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever

被引：0
|
作者：
Ali Şahin
Mehmet Emin Derin
Fatih Albayrak
Burak Karakaş
Yalçın Karagöz
机构：
[1] Cumhuriyet University,Department of Internal Medicine – Rheumatology, Faculty of Medicine
[2] Sivas Cumhuriyet University,Department of Biostatistic, Medical Faculty
来源：
Advances in Rheumatology | / 60卷
关键词：
Anakinra; Canakinumab; Familial Mediterranean fever (FMF); Amyloidosis; Colchicine-resistant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
    Eroglu, Fehime Kara
    Besbas, Nesrin
    Topaloglu, Rezan
    Ozen, Seza
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (10) : 1733 - 1737
  • [32] Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
    Fehime Kara Eroglu
    Nesrin Beşbaş
    Rezan Topaloglu
    Seza Ozen
    Rheumatology International, 2015, 35 : 1733 - 1737
  • [33] Normal Heart Rate Variability in Colchicine-Resistant Familial Mediterranean Fever Patients
    Nussinovitch, Naomi
    Esev, Konstantin
    Lidar, Merav
    Nussinovitch, Ucli
    Livneh, Avi
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (05): : 306 - 309
  • [34] Efficacy and safety of canakinumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: A single-centre observational study
    Tomokawa, Takuya
    Koga, Tomohiro
    Endo, Yushiro
    Michitsuji, Toru
    Kawakami, Atsushi
    MODERN RHEUMATOLOGY, 2022, 32 (04) : 797 - 802
  • [35] Analysis of polymorphisms in the colchicine binding site of tubulin in colchicine-resistant familial Mediterranean fever patients
    Akbaba, Tayfun Hilmi
    Ustabas, Gizem
    Kasap-Cuceloglu, Muserref
    Ozen, Seza
    Balci-Peynircioglu, Banu
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (11) : 9005 - 9011
  • [36] Analysis of polymorphisms in the colchicine binding site of tubulin in colchicine-resistant familial Mediterranean fever patients
    Tayfun Hilmi Akbaba
    Gizem Ustabas
    Muserref Kasap-Cuceloglu
    Seza Ozen
    Banu Balci-Peynircioglu
    Molecular Biology Reports, 2020, 47 : 9005 - 9011
  • [37] Anakinra for Colchicine-Resistant Familial Mediterranean Fever A Randomized, Double-Blind, Placebo-Controlled Trial
    Ben-Zvi, Ilan
    Kukuy, Olga
    Giat, Eitan
    Pras, Elon
    Feld, Olga
    Kivity, Shaye
    Perski, Oleg
    Bornstein, Gil
    Grossman, Chagai
    Harari, Gil
    Lidar, Merav
    Livneh, Avi
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (04) : 854 - 862
  • [38] Canakinumab treatment in four children with colchicine resistant familial mediterranean fever
    Ozkan, Solmaz
    Atas, Bulent
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2017, 67 (06) : 945 - 947
  • [39] QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients
    Udi Nussinovitch
    Keren Kaminer
    Moshe Nussinovitch
    Benjamin Volovitz
    Merav Lidar
    Naomi Nussinovitch
    Avi Livneh
    Clinical Rheumatology, 2012, 31 : 795 - 799
  • [40] Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever A Randomized Trial
    Hashkes, Philip J.
    Spalding, Steven J.
    Giannini, Edward H.
    Huang, Bin
    Johnson, Anne
    Park, Grace
    Barron, Karyl S.
    Weisman, Michael H.
    Pashinian, Noune
    Reiff, Andreas O.
    Samuels, Jonathan
    Wright, Dowain A.
    Kastner, Daniel L.
    Lovell, Daniel J.
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (08) : 533 - +
12345